Obtaining European patent protection for medical uses of known products is not a key factor limiting repurposing activity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Repositioning Generic Drugs: Empirical Findings and Policy Implications
IIC - International Review of Intellectual Property and Competition Law Open Access 12 September 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ashburn, T. T. & Thor, K. B. Nat. Rev. Drug Discov. 3, 673–683 (2004).
Pushpakom, S. et al. Nat. Rev. Drug Discov. 18, 41–58 (2019).
Association of Medical Research Charities. Facilitating adoption of off-patent, repurposed medicines into NHS clinical practice (AMRC, 2017).
Halabi, S. F. Yale J. Law Technol. 20, 1–51 (2018).
Breckenridge, A. & Jacob, R. Nat. Rev. Drug Discov. 18, 1–2 (2019).
Aboy, M., Liddell, K., Liddicoat, J., Crespo, C. & Jordan, M. Nat. Biotechnol. 39, 1336–1343 (2021).
Deng, Y. Eur. Econ. Rev. 51, 1785–1812 (2007).
Bubela, T. et al. Nat. Biotechnol. 31, 202–206 (2013).
Smith, J. A. et al. Nat. Biotechnol. 36, 1043–1047 (2018).
Aboy, M., Liddell, K., Liddicoat, J. & Crespo, C. Nat. Biotechnol. 34, 1119–1123 (2016).
Aboy, M., Liddicoat, J., Liddell, K., Jordan, M. & Crespo, C. Nat. Biotechnol. 35, 820–825 (2017).
Aboy, M., Crespo, C., Liddell, K., Liddicoat, J. & Jordan, M. Nat. Biotechnol. 36, 1146–1149 (2018).
EPO Guidelines for Examination. G.VI.7.1 First or further medical use of known products (EPO, 1 March 2021).
Kesselheim, A. S., Tan, Y. T. & Avorn, J. Health Aff. (Millwood) 34, 286–293 (2015).
Bühling, J. Patent Protection for Second Medical Uses (AIPPI Law Series) 2nd edn (Kluwer Law International, 2020).
Acknowledgements
The research was supported, in part, by a Novo Nordisk Foundation Grant for a scientifically independent Collaborative Research Programme in Biomedical Innovation Law (grant no. NNF17SA027784).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Aboy, M., Liddell, K., Jordan, M. et al. European patent protection for medical uses of known products and drug repurposing. Nat Biotechnol 40, 465–471 (2022). https://doi.org/10.1038/s41587-022-01269-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01269-3
This article is cited by
-
Mapping the patent landscape of medical machine learning
Nature Biotechnology (2023)
-
Repositioning Generic Drugs: Empirical Findings and Policy Implications
IIC - International Review of Intellectual Property and Competition Law (2022)